Unknown

Dataset Information

0

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis.


ABSTRACT: Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive and fatal neurodegenerative disease that leads to a loss of muscle control due to nerve cells being affected in the brain and spinal cord. Some of the common clinical presentations of ALS include weakness of muscles, changes in behavior, dysfunction in speech, and cognitive difficulties. The cause of ALS is uncertain, but through several studies, it is known that mutations in SOD1 or C9orf72 genes could play a role as a factor of ALS. In addition, studies indicate that an excessive amount of free radicals, the reactive oxygen species (ROS), leads to neuronal damage by the peroxidation of unsaturated fatty acids in the neuronal cells. Edaravone, the newly approved antioxidant drug for ALS, halts the progression of ALS in the early stages through its cytoprotective effect and protects the nerves by reducing ROS. In this review, different aspects of ALS will be discussed, including its pathology, genetic aspect, and diagnosis. This review also focuses on edaravone as a treatment option for ALS, its mechanism of action, and its pharmacological properties. Clinical trials and adverse effects of edaravone and care for ALS patient are also discussed.

SUBMITTER: Cho H 

PROVIDER: S-EPMC7823603 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Role of Edaravone as a Treatment Option for Patients with Amyotrophic Lateral Sclerosis.

Cho HaEun H   Shukla Surabhi S  

Pharmaceuticals (Basel, Switzerland) 20201231 1


Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease, is a progressive and fatal neurodegenerative disease that leads to a loss of muscle control due to nerve cells being affected in the brain and spinal cord. Some of the common clinical presentations of ALS include weakness of muscles, changes in behavior, dysfunction in speech, and cognitive difficulties. The cause of ALS is uncertain, but through several studies, it is known that mutations in SOD1 or C9orf72 genes could pla  ...[more]

Similar Datasets

| S-EPMC7841496 | biostudies-literature
2012-07-25 | E-GEOD-39644 | biostudies-arrayexpress
2003-11-14 | GSE833 | GEO
2012-07-26 | GSE39644 | GEO
| S-EPMC8382414 | biostudies-literature
| S-EPMC7004197 | biostudies-literature
| S-EPMC5024041 | biostudies-literature
| S-EPMC4266079 | biostudies-literature
| S-EPMC5810282 | biostudies-literature
| S-EPMC7536587 | biostudies-literature